BioStock: Invent Medic to accelerate with rights issue

13 September 2021 - 10:51

The Lund-based tech company Invent Medic is currently in an intensive phase in its transition towards becoming a more sales-focused company, and in the autumn the ambition is to gear up further. A rights issue of 24.1 MSEK is planned to increase sales and marketing activities for both the Efemia bladder support and the company’s upcoming product Efemia menstrual cup.

Read the full article at

This is a press release from BioStock - Connecting Innovation & Capital.

Provided by: Cision
Spotlight Stock Market (Sweden)
Invent Medic Sweden AB
Invent Medic focus on female health, where the company currently develops products for incontinence. The product is named TVS, and the vision is to improve quality of life for women with female-related health problems....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More